These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 25555391)

  • 1. The benefits, limitations, and cost-effectiveness of advanced technologies in the management of patients with diabetes mellitus.
    Vigersky RA
    J Diabetes Sci Technol; 2015 Mar; 9(2):320-30. PubMed ID: 25555391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness analysis of sensor-augmented pump therapy with low glucose-suspend in patients with type 1 diabetes mellitus and high risk of hypoglycemia in Spain.
    Conget I; Martín-Vaquero P; Roze S; Elías I; Pineda C; Álvarez M; Delbaere A; Ampudia-Blasco FJ
    Endocrinol Diabetes Nutr (Engl Ed); 2018; 65(7):380-386. PubMed ID: 29789227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term health economic benefits of sensor-augmented pump therapy vs continuous subcutaneous insulin infusion alone in type 1 diabetes: a U.K. perspective.
    Roze S; Smith-Palmer J; Valentine WJ; Cook M; Jethwa M; de Portu S; Pickup JC
    J Med Econ; 2016; 19(3):236-42. PubMed ID: 26510389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-Effectiveness of Sensor-Augmented Pump Therapy with Low Glucose Suspend Versus Standard Insulin Pump Therapy in Two Different Patient Populations with Type 1 Diabetes in France.
    Roze S; Smith-Palmer J; Valentine W; Payet V; de Portu S; Papo N; Cucherat M; Hanaire H
    Diabetes Technol Ther; 2016 Feb; 18(2):75-84. PubMed ID: 26646072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-Effectiveness Analysis of the MiniMed 670G Hybrid Closed-Loop System Versus Continuous Subcutaneous Insulin Infusion for Treatment of Type 1 Diabetes.
    Jendle J; Pöhlmann J; de Portu S; Smith-Palmer J; Roze S
    Diabetes Technol Ther; 2019 Mar; 21(3):110-118. PubMed ID: 30785311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating optimal utilisation of technology in type 1 diabetes mellitus from a clinical and health economic perspective: protocol for a systematic review.
    Pease A; Lo C; Earnest A; Liew D; Zoungas S
    Syst Rev; 2018 Mar; 7(1):44. PubMed ID: 29530081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Potential Cost Implications of Averting Severe Hypoglycemic Events Requiring Hospitalization in High-Risk Adults With Type 1 Diabetes Using Real-Time Continuous Glucose Monitoring.
    Bronstone A; Graham C
    J Diabetes Sci Technol; 2016 Jul; 10(4):905-13. PubMed ID: 26880392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and economic benefits of integrated pump/CGM technology therapy in patients with type 1 diabetes in Colombia.
    Gomez AM; Alfonso-Cristancho R; Orozco JJ; Lynch PM; Prieto D; Saunders R; Roze S; Valencia JE
    Endocrinol Nutr; 2016 Nov; 63(9):466-474. PubMed ID: 27595241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of sensor-augmented pump therapy versus standard insulin pump therapy in patients with type 1 diabetes in Denmark.
    Roze S; de Portu S; Smith-Palmer J; Delbaere A; Valentine W; Ridderstråle M
    Diabetes Res Clin Pract; 2017 Jun; 128():6-14. PubMed ID: 28432898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Efficacy of Technology in Type 1 Diabetes: A Systematic Review, Network Meta-analysis, and Narrative Synthesis.
    Pease A; Lo C; Earnest A; Kiriakova V; Liew D; Zoungas S
    Diabetes Technol Ther; 2020 May; 22(5):411-421. PubMed ID: 31904262
    [No Abstract]   [Full Text] [Related]  

  • 11. Diabetes technology and treatments in the paediatric age group.
    Shalitin S; Peter Chase H
    Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous Glucose Monitoring, Future Products, and Update on Worldwide Artificial Pancreas Projects.
    Kropff J; DeVries JH
    Diabetes Technol Ther; 2016 Feb; 18 Suppl 2(Suppl 2):S253-63. PubMed ID: 26784131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous Glucose Monitoring Associated With Less Diabetes-Specific Emotional Distress and Lower A1c Among Adolescents With Type 1 Diabetes.
    Vesco AT; Jedraszko AM; Garza KP; Weissberg-Benchell J
    J Diabetes Sci Technol; 2018 Jul; 12(4):792-799. PubMed ID: 29595061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of new technologies on diabetes care.
    Giani E; Scaramuzza AE; Zuccotti GV
    World J Diabetes; 2015 Jul; 6(8):999-1004. PubMed ID: 26240696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous Glucose Monitoring Sensors for Diabetes Management: A Review of Technologies and Applications.
    Cappon G; Vettoretti M; Sparacino G; Facchinetti A
    Diabetes Metab J; 2019 Aug; 43(4):383-397. PubMed ID: 31441246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advanced Technology in the Management of Diabetes: Which Comes First-Continuous Glucose Monitor or Insulin Pump?
    Martin CT; Criego AB; Carlson AL; Bergenstal RM
    Curr Diab Rep; 2019 Jun; 19(8):50. PubMed ID: 31250124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Insulin Pump Therapy and Multiple Daily Injections Insulin Regimen in Patients with Type 1 Diabetes During Ramadan Fasting.
    Alamoudi R; Alsubaiee M; Alqarni A; Saleh Y; Aljaser S; Salam A; Eledrisi M
    Diabetes Technol Ther; 2017 Jun; 19(6):349-354. PubMed ID: 28296467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained efficacy of continuous subcutaneous insulin infusion in type 1 diabetes subjects with recurrent non-severe and severe hypoglycemia and hypoglycemia unawareness: a pilot study.
    Giménez M; Lara M; Conget I
    Diabetes Technol Ther; 2010 Jul; 12(7):517-21. PubMed ID: 20597825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention and Management of Severe Hypoglycemia and Hypoglycemia Unawareness: Incorporating Sensor Technology.
    Lucidi P; Porcellati F; Bolli GB; Fanelli CG
    Curr Diab Rep; 2018 Aug; 18(10):83. PubMed ID: 30121746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient-reported outcomes for an integrated real-time continuous glucose monitoring/insulin pump system.
    Peyrot M; Rubin RR
    Diabetes Technol Ther; 2009 Jan; 11(1):57-62. PubMed ID: 19132857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.